C
Celine S L Chui
Researcher at University of Hong Kong
Publications - 54
Citations - 1114
Celine S L Chui is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 15, co-authored 33 publications receiving 733 citations. Previous affiliations of Celine S L Chui include Li Ka Shing Faculty of Medicine, University of Hong Kong & University of London.
Papers
More filters
Journal ArticleDOI
Cardiovascular outcomes associated with use of clarithromycin: population based study.
Angel Y S Wong,Adrian Root,Ian J. Douglas,Celine S L Chui,Esther W. Chan,Yonas Ghebremichael-Weldeselassie,Chung-Wah Siu,Liam Smeeth,Ian C. K. Wong,Ian C. K. Wong +9 more
TL;DR: Current use of clarithromycin was associated with an increased risk of myocardial infarction, arrhythmia, and cardiac mortality short term but no association with long term cardiovascular risks among the Hong Kong population.
Journal ArticleDOI
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review.
T. Y. M. Leung,A. Y. L. Chan,Esther W. Chan,V. K. Y. Chan,Celine S L Chui,Benjamin J. Cowling,L. Gao,M. Q. Ge,Ivan Fn Hung,M. S. M. Ip,Patrick Ip,Kui Kai Lau,C. S. Lau,L. K. W. Lau,W. K. Leung,Xue Li,Hao Luo,Kenneth K.C. Man,Kenneth K.C. Man,V. W. S. Ng,C. W. Siu,E. Y. F. Wan,Y. K. Wing,C. S. M. Wong,C. S. M. Wong,K. H. T. Wong,Ian C. K. Wong,Ian C. K. Wong +27 more
TL;DR: The coronavirus disease 2019 (COVID-19) pandemic has resulted in millions of patients infected worldwide and indirectly affecting even more individuals through disruption of daily living and is important for policy makers to develop comprehensive strategies in providing resources and capacity in the healthcare system.
Journal ArticleDOI
Efficacy and safety of lorcaserin in obese adults: a meta-analysis of 1-year randomized controlled trials (RCTs) and narrative review on short-term RCTs.
TL;DR: Clinical and pharmacovigilance studies with longer study duration are needed to inform of the long‐term efficacy and safety of lorcaserin, which achieves modest weight loss and appears to be well tolerated.
Journal ArticleDOI
Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis
Y He,Angel Y S Wong,Esther W. Chan,Wallis C.Y. Lau,Kenneth K.C. Man,Celine S L Chui,Alan J. Worsley,Ian C. K. Wong +7 more
TL;DR: Tofacitinib is efficacious and well tolerated in patients with MTX-resistant RA up to a period of 24 weeks, however, haematological, liver function tests and lipoproteins should be monitored.
Journal ArticleDOI
ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong Kong.
Kenneth K.C. Man,Patrick Ip,Yingfen Hsia,Yingfen Hsia,Esther W. Chan,Celine S L Chui,May P. S. Lam,Wilfred Hing Sang Wong,Chun Bong Chow,Ada Yung,Ian C. K. Wong,Ian C. K. Wong +11 more
TL;DR: The prevalence of ADHD medication prescribing in Hong Kong is increasing but remains lower than most Western countries, however, the prevalence of ADD medication prescribing for kindergarten children should be monitored to ensure appropriate use.